0001123292-18-000423.txt : 20180228
0001123292-18-000423.hdr.sgml : 20180228
20180228103417
ACCESSION NUMBER: 0001123292-18-000423
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHANG LINDA L
CENTRAL INDEX KEY: 0001535179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 18648622
MAIL ADDRESS:
STREET 1: ONE PARK PLACE
STREET 2: STE 450
CITY: ANNAPOLIS
STATE: MD
ZIP: 21401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-02-26
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001535179
CHANG LINDA L
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046
0
1
0
0
Chief Financial Officer
Incentive Stock Option (right to buy)
8.92
2018-02-26
4
A
0
20000
8.92
A
2019-02-26
2028-02-25
Common Stock
20000
20000
D
5,000 shares underlying this option shall vest on each of February 26, 2019, February 26, 2020, February 26, 2021 and February 26, 2022, subject to Reporting Person's continued service through the applicable vesting date.
/s/ Linda L. Chang
2018-02-28